×
About 33,979 results

AllMedicine All Center

Research & Reviews  16,127 results

Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
https://doi.org/10.1002/ana.24582
Annals of Neurology; Flanagan EP, Kaufmann TJ et. al.

Dec 17th, 2015 - To compare longitudinally extensive myelitis in neuromyelitis optica spectrum disorders (NMOSD) and spinal cord sarcoidosis (SCS). We identified adult patients evaluated between 1996 and 2015 with SCS or NMOSD whose first myelitis episode was acco...

A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomid...
https://doi.org/10.1378/chest.14-0015
Chest Droitcourt C, Rybojad M et. al.

Jun 19th, 2014 - Thalidomide use in cutaneous sarcoidosis is based on data from small case series or case reports. The objective of this study was to evaluate the efficacy and safety of thalidomide in severe cutaneous sarcoidosis. This study consisted of a randomi...

Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis.
https://doi.org/10.1164/rccm.201902-0456OC
American Journal of Respiratory and Critical Care Medicine; Dempsey TM, Sangaralingham LR et. al.

May 31st, 2019 - Rationale: Since their approval, there has been no real-world or randomized trial evidence evaluating the effect of the antifibrotic medications pirfenidone and nintedanib on clinically important outcomes such as mortality and hospitalizations. Ob...

Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.
https://doi.org/10.1056/NEJMoa1811737
The New England Journal of Medicine; Kolb M, Raghu G et. al.

Sep 17th, 2018 - Nintedanib is an approved treatment for idiopathic pulmonary fibrosis (IPF). A subgroup analysis of a previously published trial suggested that sildenafil may provide benefits regarding oxygenation, gas exchange as measured by the diffusion capaci...

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoi...
https://doi.org/10.1001/jamaneurol.2018.2295
JAMA Neurology; Stern BJ, Royal W et. al.

Aug 31st, 2018 - The Neurosarcoidosis Consortium Consensus Group, an expert panel of physicians experienced in the management of patients with sarcoidosis and neurosarcoidosis, engaged in an iterative process to define neurosarcoidosis and develop a practical diag...

see more →

Guidelines  23 results

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice G...
https://www.atsjournals.org/doi/10.1164/rccm.201807-1255ST
Raghu, G.

Aug 31st, 2018 - This document provides clinical recommendations for the diagnosis of idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and.

Evaluation of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society ...
https://cts-sct.ca/wp-content/uploads/2018/02/Evaluation-of-pts-w_ILD-paper.pdf
Kerri A. Johannson

Aug 21st, 2017 - Fibrotic ILD represents a large heterogeneous group of disorders that are challenging to diagnose. The evaluation of patients with fibrotic ILD should include a thorough history, physical examination, basic serological testing, pulmonary function.

Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fib...
http://www.thoracic.org/statements/resources/interstitial-lung-disease/animal-models-pulm-fibrosis.pdf
R. Gisli Jenkins

Apr 30th, 2017 - Numerous compounds have shown efficacy in limiting development of pulmonary fibrosis using animal models, yet few of these compounds have replicated these beneficial effects in clinical trials. Given the challenges associated with performing clini.

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary ...
http://www.thoracic.org/statements/resources/interstitial-lung-disease/IPF-Full-length.pdf
Ganesh Raghu

Jul 14th, 2015 - After considering the confidence in effect estimates, the importance of outcomes studied, desirable and undesirable consequences of treatment, cost, feasibility, acceptability of the intervention, and implications to health equity, recommendations.

An official American Thoracic Society clinical practice guideline: the clinical utility...
https://doi.org/10.1164/rccm.201202-0320ST
American Journal of Respiratory and Critical Care Medicine; Meyer KC, Raghu G et. al.

May 2nd, 2012 - The clinical utility of bronchoalveolar lavage fluid (BAL) cell analysis for the diagnosis and management of patients with interstitial lung disease (ILD) has been a subject of debate and controversy. The American Thoracic Society (ATS) sponsored ...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  16,827 results

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice G...
https://www.atsjournals.org/doi/10.1164/rccm.201807-1255ST
Raghu, G.

Aug 31st, 2018 - This document provides clinical recommendations for the diagnosis of idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and.

Evaluation of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society ...
https://cts-sct.ca/wp-content/uploads/2018/02/Evaluation-of-pts-w_ILD-paper.pdf
Kerri A. Johannson

Aug 21st, 2017 - Fibrotic ILD represents a large heterogeneous group of disorders that are challenging to diagnose. The evaluation of patients with fibrotic ILD should include a thorough history, physical examination, basic serological testing, pulmonary function.

Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fib...
http://www.thoracic.org/statements/resources/interstitial-lung-disease/animal-models-pulm-fibrosis.pdf
R. Gisli Jenkins

Apr 30th, 2017 - Numerous compounds have shown efficacy in limiting development of pulmonary fibrosis using animal models, yet few of these compounds have replicated these beneficial effects in clinical trials. Given the challenges associated with performing clini.

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary ...
http://www.thoracic.org/statements/resources/interstitial-lung-disease/IPF-Full-length.pdf
Ganesh Raghu

Jul 14th, 2015 - After considering the confidence in effect estimates, the importance of outcomes studied, desirable and undesirable consequences of treatment, cost, feasibility, acceptability of the intervention, and implications to health equity, recommendations.

Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
https://doi.org/10.1002/ana.24582
Annals of Neurology; Flanagan EP, Kaufmann TJ et. al.

Dec 17th, 2015 - To compare longitudinally extensive myelitis in neuromyelitis optica spectrum disorders (NMOSD) and spinal cord sarcoidosis (SCS). We identified adult patients evaluated between 1996 and 2015 with SCS or NMOSD whose first myelitis episode was acco...

see more →

News  957 results

FDA broadens nintedanib interstitial lung disease indication
https://www.mdedge.com/internalmedicine/article/218826/pulmonology/fda-broadens-nintedanib-interstitial-lung-disease?channel=39313
Mitchel L. Zoler

Mar 11th, 2020 - A new indication for the tyrosine kinase inhibitor nintedanib approved by the Food and Drug Administration on March 9, 2020, broadened the drug’s targeted population to include patients with chronic fibrosing interstitial lung diseases with a prog.

Disaster response. Medicare billing. Lung transplantation. Asthma.
https://www.mdedge.com/chestphysician/article/217418/society-news/disaster-response-medicare-billing-lung-transplantation/page/0/1?channel=39299

Mar 10th, 2020 - Transplant Investigating clinical practice of lung transplantation in systemic sclerosis Interstitial lung disease (ILD) as a sequela of systemic sclerosis (SSc) poses a significant health concern. Patients with SSc-ILD experience symptoms of shor.

Roche Pushes to Kick-Start Lung Therapy Esbriet After Big Writedown
https://www.medscape.com/viewarticle/926124

Mar 4th, 2020 - ZURICH, March 3 (Reuters) - Roche has won U.S. breakthrough therapy status for Esbriet for unclassifiable interstitial lung disease (uILD), the company said on Tuesday, as it aims to lift disappointing revenue by expanding conditions for which it ...

Idiopathic pulmonary fibrosis in an era of personalized medicine
https://www.mdedge.com/pulmonary-health-hub/article/217385/pulmonology/idiopathic-pulmonary-fibrosis-era-personalized?channel=284
Lisa Hack

Feb 18th, 2020 - Useful not only as a clinical overview but also for patient information, these up-to-date statistics elucidate the symptoms and prevalence of pulmonary fibrosis; and recommendations for personalized treatment. To see the data in action, start read.

High-Res CT Has Key Role Detecting Lung Disease in Systemic Sclerosis
https://www.medscape.com/viewarticle/924647

Feb 3rd, 2020 - NEW YORK (Reuters Health) - The first evidence-based consensus statements for systemic sclerosis-associated interstitial lung disease (SSc-ILD) recommend use of high-resolution computed tomography (CT) for screening and diagnosis, and offer guidan...

see more →

Patient Education  41 results see all →